Dr. Cherian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1145 Olentangy River Rd
Columbus, OH 43212Phone+1 614-293-0066Fax+1 614-293-7264
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2009 - 2012
- University of North DakotaResidency, Internal Medicine, 2003 - 2006
- Christian Medical College VelloreClass of 2000
Certifications & Licensure
- OH State Medical License 2018 - 2025
- IL State Medical License 2018 - 2020
- MO State Medical License 2009 - 2019
- ND State Medical License 2003 - 2009
- MN State Medical License 2006 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Paul Calabresi NIH K12 Oncology Award 2016
- American Society of Hematology Research Training Award for Fellows 2012
Clinical Trials
- Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation Start of enrollment: 2023 Oct 31
Roles: Contact
Publications & Presentations
PubMed
- 15 citationsMatched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness.Otto Metzger-Filho, Katharine Collier, Sarah Asad, Peter Ansell, Mark A. Watson
NPJ Breast Cancer. 2021-11-11 - 86 citationsPexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development.Brooke Benner, Logan Good, Dionisia Quiroga, Thomas E Schultz, Mahmoud Kassem
Drug Design, Development and Therapy. 2020-05-04 - 5 citationsDepression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer Survivorship.Annelise A Madison, Rebecca Andridge, Anthony H Kantaras, Megan E Renna, Jeanette M Bennett
Cancers. 2023-09-04
Journal Articles
- An Activating Mutation of Interferon Regulatory Factor 4 (IRF4) in Adult T Cell LeukemiaCherian MA, Olson S, Sundaramoorthi H, Cates K, Cheng X, Harding J, Martens A, Challen GA, Tyagi M, Ratner L, Rauch D, J Biol Chem, 1/14/2018
- The Role of Neratinib in HER2 Driven Breast CancerCherian MA, Ma CX, Future Oncol, 1/20/2017
- A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndromeCherian MA, Tibes R, Gao F, Fletcher T, Fiala M, Uy GL, Westervelt P, Jacoby MA, Cashen AF, Stockerl-Goldstein K, DiPersio JF, Vij R, Leuk Lymphoma, 1/1/2016
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: